Bertagnolli: NIH funding cuts are “unprecedented and harmful” AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

Anthony Letai sworn in as 18th NCI director

Anthony G. Letai, accompanied by his wife Jean, was sworn in by HHS Secretary Kennedy as the 18th NCI Director on Sept. 29.Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute, has been officially named the 18th director of the National Cancer Institute.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

Capitol Hill

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

On Oct. 1, for the first time in six years, the U.S. government shut down after Congress was unable to reach a deal to fund federal agencies for Fiscal Year 2026.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

Cancer Policy

Trump signs order to use AI to accelerate pediatric cancer research

President Trump has signed an executive order to use artificial intelligence to accelerate research in pediatric cancers.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

In Brief

Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research

From left to right: Geoffrey Shapiro, Leif Ellisen and Nancy Lin. Sitting below them is Kornelia Polyak.The Dana-Farber/Harvard Cancer Center, a cancer research consortium comprised of five of Boston’s academic medical centers, including Dana-Farber Cancer Institute and Massachusetts General Hospital, has been awarded an NCI grant to continue its Specialized Program of Research Excellence in Breast Cancer.

October 03, 2025

Vol.51 No.36

In Brief

The University of Cincinnati researchers win NCI grant to study combination colorectal cancer treatment

The University of Cincinnati Cancer Center’s Joan Garrett has received a two-year, $162,000 NCI grant to study a new combination approach to treat KRAS-mutated colorectal cancers.

October 03, 2025

Vol.51 No.36

Podcast

With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown

With little fanfare, Anthony Letai, a highly respected physician-scientist, was sworn in as the 18th director of the National Cancer Institute on Sept. 29. Then, two days later, on Oct. 1, the government shut down.

October 01, 2025

Bertagnolli: NIH funding cuts are “unprecedented and harmful”

AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

YOU MAY BE INTERESTED IN

Anthony Letai sworn in as 18th NCI director

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

Trump signs order to use AI to accelerate pediatric cancer research

Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research

The University of Cincinnati researchers win NCI grant to study combination colorectal cancer treatment

With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown

Renew today!

Subscriber content

Never miss an issue!

Login

Bertagnolli: NIH funding cuts are “unprecedented and harmful”

AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

YOU MAY BE INTERESTED IN

Anthony Letai sworn in as 18th NCI director

U.S. government shuts downImpact on NCI uncertain as administration threatens more RIFs

Trump signs order to use AI to accelerate pediatric cancer research

Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research

The University of Cincinnati researchers win NCI grant to study combination colorectal cancer treatment

With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown

Never miss an issue!

Login

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs